Rhett Wilkerson: Financial Toxicity in Cancer Care

Video

Rhett Wilkerson, associate director of patient financial services, Florida Cancer Specialists, discusses financial toxicity in cancer care.

Transcript

So that is something that, as deductibles and out-of-pockets continue to rise, is something that is prevalent. Being able to be aggressive about reaching out finding copay assistance or foundations or grants that are appropriate for the patient is one way that, you know, we work to alleviate that.

But then also, again, knowing those drug costs and being able to put together successful payment plans that cover, you know, the cost of the drug, and kind of looking at the whole episode of care to really make an aggressive payment plan that fits, that's something that the patient can make and then also covers the cost of the drug.

Related Videos
Fran Gregory, PharmD, MBA
Julie Reed, MS
Julie Reed, executive director of the Biosimilars Forum
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Ryan Haumschild, PharmD, MS, MBA
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
andre harvin
Andre Harvin, PharmD
Related Content
© 2023 MJH Life Sciences

All rights reserved.